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Ventricular Geometry From
Non-contrast Non-ECG-gated
CT Scans:
An Imaging Marker of Cardiopulmonary
Disease in Smokers
Farbod N. Rahaghi1, Gonzalo Vegas-Sanchez-Ferrero1, Jasleen K. Minhas, Carolyn E. Come,
Isaac De La Bruere, James M. Wells, Germán González, Surya P. Bhatt, Brett E. Fenster,
Alejandro A. Diaz, Puja Kohli, James C. Ross, David A. Lynch, Mark T. Dransfield, Russel P. Bowler,
Maria J. Ledesma-Carbayo, Raúl San José Estépar1, George R. Washko1, the COPDGene
Investigators
Rationale and Objectives: Imaging-based assessment of cardiovascular structure and function provides clinically relevant informa-
tion in smokers. Non-cardiac-gated thoracic computed tomographic (CT) scanning is increasingly leveraged for clinical care and lung
cancer screening. We sought to determine if more comprehensive measures of ventricular geometry could be obtained from CT using
an atlas-based surface model of the heart.
Materials and Methods: Subcohorts of 24 subjects with cardiac magnetic resonance imaging (MRI) and 262 subjects with echocardiography
were identified from COPDGene, a longitudinal observational study of smokers. A surface model of the heart was manually initialized,
and then automatically optimized to fit the epicardium for each CT. Estimates of right and left ventricular (RV and LV) volume and free-
wall curvature were then calculated and compared to structural and functional metrics obtained from MRI and echocardiograms.
Results: CT measures of RV dimension and curvature correlated with similar measures obtained using MRI. RV and LV volume ob-
tained from CT inversely correlated with echocardiogram-based estimates of RV systolic pressure using tricuspid regurgitation jet velocity
and LV ejection fraction respectively. Patients with evidence of RV or LV dysfunction on echocardiogram had larger RV and LV dimen-
sions on CT. Logistic regression models based on demographics and ventricular measures from CT had an area under the curve of
>0.7 for the prediction of elevated right ventricular systolic pressure and ventricular failure.
Conclusions: These data suggest that non-cardiac-gated, non-contrast-enhanced thoracic CT scanning may provide insight into cardiac
structure and function in smokers.
Key Words: Non-ECG-gated; non-contrast; computed tomography; ventricular volume; ventricular geometry; heart; cardiac; smokers;
COPD; COPDGene; congestive heart failure; echocardiography; pulmonary hypertension; right heart failure; left heart failure
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INTRODUCTION
C ardiovascular disease is a major cause of morbidityin smokers, and as much as 50% of the estimated 24million patients in the United States with chronic
obstructive pulmonary disease (COPD) die of cardiovascu-
lar causes (1,2). Although echocardiography and cardiac
magnetic resonance imaging (MRI) are often used to study
cardiac structure and function in COPD (3), these are not
routinely deployed in all smokers. Computed tomographic
(CT) imaging of the chest is broadly used in clinical care and
is increasingly used for lung cancer screening in high-risk
smokers (4). Assessment of cardiac structure on those CT scans
may help identify patients with COPD at greater risk of de-
veloping cardiac dysfunction. Rapid, noninvasive assessments
of cardiac morphology and a better understanding of the func-
tional interdependence of heart and lung may improve
healthcare outcomes through early detection and initiation of
treatment.
CT has been used to quantify coronary and thoracic aortic
calcification (5), study the size of the pulmonary artery and
aorta (2,6–8), and describe the relationship between pulmo-
nary vascular and parenchymal disease progression (9,10). The
caliber of other vessels such as the pulmonary veins has been
explored as an image-based metric of volume status (11).
Most screening CT scans and those obtained in large mul-
ticenter studies and trials are non-electrocardiography (ECG)-
gated and do not use contrast, posing significant limitation
to cardiac segmentation and quantification of volume. Al-
though previous studies of manual measurements of right
ventricular-to-left ventricular (RV-to-LV) ratio have shown
that ECG gating is not strictly required for the specific markers
of RV dilation in pulmonary embolus, these studies still used
contrast (12). Non-gated CT scans lead to cardiac motion
during the scan whereby the exact boundary of the heart
depends on the cardiac cycle during which the image is cap-
tured. Lack of contrast prevents simple segmentation of the
ventricular septum.
Previously, we developed a method to generate a surface
model of the heart from ultrasound images (13,14). We
sought to adapt this methodology to non-ECG-gated and
non-contrast thoracic CT scans and then explore the utility
of the resulting data. We hypothesized that a model fit to
the surface of the heart of non-cardiac-gated volumetric
CT data could provide assessments of ventricular size,
shape, and function. To test this hypothesis, we identified
a subset of subjects enrolled in the Genetic Epidemiology
of COPD (COPDGene) Study who underwent additional
cardiac MRI or echocardiographic assessments of the
heart. Whereas for the purpose of this study, the location of
the heart was manually determined before deployment of
the cardiac fitting algorithm, fully automated algorithms
may be developed that would then permit automated
objective quantification of cardiac geometry from non-
contrast non-ECG-gated CT scans for further research and
population screening purposes.
METHODS
COPDGene Study
The COPDGene Study has been described in detail previ-
ously (15). Briefly, it is a National Heart, Lung, and Blood
Institute-funded investigation of the epidemiologic and genetic
determinants of COPD in more than 10,000 current and former
smokers. Subjects with active lung diseases other than COPD
and asthma were excluded from participation. Each subject
underwent detailed characterization including spirometric as-
sessments of lung function. Additional data collected included
self-reported physician-diagnosed medical history. Volumet-
ric CT scans of the chest were acquired at full inspiration
following the standardized COPDGene Study imaging pro-
tocol with 120 kVp, tube current of 200 mAs, and 0.5 seconds
rotation time. The COPDGene study was approved by the
institutional review board at each participating clinical center,
and all subjects provided written informed consent.
Cardiac MRI Cohort
As part of the COPDGene Study, 24 subjects free of a docu-
mented history of pulmonary vascular or cardiac disease
additionally underwent cardiac MRI (16). This cohort was
used to validate the CT measurements of ventricular geom-
etry against related measures made with MRI. Because this
was a follow-up study that was not part of the initial
COPDGene recruitment, the MRI images were obtained about
3 years after the CT scan was obtained. Images were ob-
tained using a 1.5 T scanner (Signa CV/i, GE Healthcare,
Milwaukee, WI). A phased array cardiac coil, prospective elec-
trocardiographic triggering, and retrospective gating were used.
Typical imaging parameters were field of view of 36–
44 cm, flip angle of 35–45 degrees, matrix size of 256 in the
frequency domain and 128–256 in the phase domain, relax-
ation time of 3.7–4.1 ms, and echocardiogram time of 1.5–
1.7 ms. The end-diastolic (ED) horizontal long-axis image
provided the reference from which a stack of contiguous short-
axis slices of 8-mm thickness and 0-mm gap were obtained.
Echocardiography Cohort
A total of 262 patients from a single center with clinically ac-
quired echocardiograms performed at the time of enrollment
in the COPDGene Study were retrospectively identified. These
subjects underwent echocardiographic assessment in addi-
tion to the standard evaluation performed at study enrollment.
On average, these echocardiograms were obtained within 73
days of the CT scan. Overall RV function, estimated RV sys-
tolic pressure (RVSP), estimated LV ejection fraction (LVEF),
or comments about whether the LVEF was greater than or
less than 55% were documented in subsets of the
echocardiogram reports. This cohort was used to study the
associations between ventricular geometry acquired from CT
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scan and both geometrical and functional correlates with
echocardiography.
Cardiac Modeling
A detailed overview of the methodology is provided in the
supplement. Briefly, we used a statistical model of the human
heart that uses 50 modes of variation (non-affine deforma-
tions of cardiac structure) to describe anatomical variability
(17). This model was developed from the anatomical seg-
mentations of three-dimensional + time data sets of 138 subjects
including patients without disease as well as those with a broad
range of pathologic conditions to facilitate generalization of
the model.
The supervised segmentation process begins with a manual
initialization of the average shape model within the region
of interest (performed by a trained operator) followed by an
automated iteration of the deformation to optimize surface
identification of the heart in the CT scan. The surface fitting
is assisted by a “probabilistic driven initialization” to deter-
mine the boundary between pericardial fat and myocardium.
This mode selected vertices in the normal direction of the
manually initialized surface and examined the distribution of
the attenuation values along those vertices in a window from
−200 to 200 HU.
Based on the assumption that there are two tissues present
in a single pathway (pericardial fat and then myocardium as
one travels the path toward the centroid of the heart), a mixture
of two components of non-central gamma distributions was
fitted in the attenuation window (18,19). The lower distri-
bution in this window represented the pericardial fat, whereas
the higher attenuation distribution characterized the blood or
muscle (Fig S2). Voxels are then designated as belonging to
either the fat or the muscle and can be labeled as demon-
strated in Figure S3.
The metrics of cardiovascular morphology extracted in-
cluded the free-wall curvatures as well as estimates of the
epicardial volume (wall + chamber). Endocardial volume
(chamber size) for both the right and the left ventricles was
estimated based on atlas models of the heart that were fitted
to the epicardial surface model. Herein, these are referred to
as the RV_EPI volumeCT, RV_ENDO volumeCT, LV_EPI
volumeCT, and LV_ENDO volumeCT, respectively. All other
measures of ventricular axes length and surface area were ob-
tained from the epicardial surface fitting model. Sphericity was
defined as:
Sphericity
V
S
=
( )
π
1
3
2
36
where V is the volume and S is the surface area of the ventricle.
The free wall was defined as the surface segments not in contact
with the septum. The curvature estimate was defined as
Curvature =
+( )κ κ12 22
2
where κ1 is the minimum and κ 2 is the maximum curva-
ture of the surface (20).
Statistical Analysis
Data are presented as means and standard deviations or medians
and interquartile ranges where appropriate. Intra-subject sta-
bility of measures was assessed with Pearson correlation
coefficients. Concordance coefficients were used to assess intra-
and interoperator agreement (21). Associations between CT-
derived measures of cardiac morphology and MRI- and
echocardiogram-based measures of cardiac structure and func-
tion were expressed using nonparametric (Spearman) correlation
coefficients. Group-to-group comparisons were evaluated using
the Wilcoxon rank sum test. Logistic regression models (22)
for outcomes of interest were created using a stepwise forward
selection method using the measures of ventricular volume,
as well as age at enrollment, gender, height, and body mass
index. From these candidate variables, those with statistical-
ly significant P values using the Wald test were retained in
the model. Interaction terms were included in subsequent
models if they reached statistical significance or if they ex-
hibited a P value of less than .1 and improved model
performance. Logistic regression models and receiver oper-
ating characteristic curve generation were performed using
Stata 14 (StataCorp, College Station, TX). All other statis-
tical analyses were performed using SAS 9.3 (SAS Institute,
Cary, NC). P values less than .05 were considered statisti-
cally significant.
RESULTS
Reproducibility of CT-based Measures of Ventricular
Geometry
Data from 11 subjects who had violated study protocol by
enrolling at more than one center, and thus had received CT
scans at both visits, were used to assess the intra-subject re-
producibility. CT-based measurements of all 11 subjects in
the dual enrollment group (demographic information shown
in Table 1, column A) was performed by a single operator.
The second CT scan in the dual enrollment cohort oc-
curred at a median interval of 201 days from the first scan.
There was a strong correlation between the first and the second
baseline measures of RV and LV volume (R = 0.86, P < .001;
R = 0.87, P < .001 respectively).
The MRI cohort was used to explore the intra- and
interoperator reproducibility in fitting the heart surface model
to the CT scan. The demographics for the MRI cohort is
shown in Table 1, column B. The mean age for this cohort
was 59 ± 9 years, with a mean forced expiratory volume in
1 second of 52 ± 16% of predicted. Intraoperator agreement
on assessments of RV and LV volume was excellent, with con-
cordance coefficients of 0.92 for RV volume and 0.98 for
LV volume (Table S1). Inter-concordance coefficients are
RAHAGHI ET AL Academic Radiology, Vol 24, No 5, May 2017
596
shown in Table S2, with concordance coefficients ranging from
0.91 to 0.97.
Validation of CT-based Ventricular Geometry as
Compared to MRI Measures
The associations of CT and MRI assessments of ventricular
dimensions were explored using data from MRI cohort and
is presented in Table 2. The CT-based estimates of RV volume
(RV_EPI volumeCT and RV_ENDO volumeCT) were sig-
nificantly associated with both the ED RV volume (RV ED
volumeMR) and the mass (RV ED massMR) obtained from MRI.
There were similarly significant associations between CT and
MRI LV measures. CT-based estimates of the long-axis di-
mension of the LV (LV Long AxisCT) were related to this same
measure (LV ED lengthMR) obtained from MR as were mea-
sures of the free-wall curvature of the ventricle (LV Free Wall
curvatureCT and LV mid ED curvatureMR). The sphericity of
the LV on CT scan (LV sphericityCT) was also significantly
related to the long- to short-axis radius ratio of the LV ob-
tained from MRI (LV ED radius ratioMR). Finally, the CT-
derived ratio of RV-to-LV volume (RV-to-LV volume ratioCT)
was significantly associated with the ratio of those same mea-
sures obtained from MRI (RV/LV ED volume ratioMR).
Association Between CT-based Ventricular Geometry
and Echocardiographic-based Ventricular Structure
and Function
Examples of chamber models reconstructed for three subjects with
echocardiograms are shown in Figure 1. The mean age for the
echocardiogram cohort was 64.7 ± 9 years with a mean forced
expiratory volume in 1 second of 47 ± 23% predicted (addi-
tional demographic information in Table 1, column C). The
RV Long AxisCT and the RV short AxisCT were signifi-
cantly associated with RV Minor axisECHO obtained from
echocardiography. The RV_EPI and RV_ENDO volumeCT
and RV surface areaCT were also related to echocardiogram-
derived axis measurements. One hundred and ninety-four of
the 262 echocardiograms reported an estimated RVSP. This
RVSP was directly related to CT measures of RV size
(RV_EPI volumeCT, RV_ENDO volumeCT, RV Long AxisCT,
RV Short AxisCT, and RV surface areaCT). In addition, 130
of the echocardiogram reports were noted to have descrip-
tions of RV function as being normal (n = 120) or decreased
(n = 10). There were statistically significant differences in the
CT-based measures of RV size in those with decreased RV
function versus those with preserved function (Table 3).
TABLE 1. Demographics of Two Cohorts Used in This
Study, Both Subsets of the COPDGene Study
Variable
(A) (B) (C)
Dual
Enrollment
MRI
Cohort
ECHO
Cohort
(N = 11) (N = 24) (N = 262)
Demographics
Age (y) 52 ± 8 59 ± 9 65 ± 9
White race 10 (91%) 14 (58%) 250 (95%)
Male sex 11 (100%) 16 (67%) 126 (48%)
BMI 29 ± 9 29 ± 8 28 ± 7
BSA (m2) 2.06 ± 0.25 1.99 ± 0.22 1.93 ± .28
6-minute walk
distance (ft)
1105 ± 552 1069 ± 209 1173 ± 365
Lung function
FEV1 % predicted 70 ± 22 57 ± 27 47 ± 23
FEV1-to-FVC ratio 0.68 ± 0.17 0.52 ± 0.16 0.46 ± 0.17
TLCpp
(Race adjusted, L)
76 ± 20 102 ± 14 106 ± 19
(N = 257)
MRI
LVEF (%) 64 ± 8
RVEF (%) 58 ± 10
RVESVI 24 ± 9
RVMI 13 ± 4
ECHO
RV minor axis 3.24 ± 0.54
(N = 238)
RVSP 36.0 ± 13.22
LVEF (%) 64.1 ± 7.7
BMI, body mass index; BSA, estimated body surface area;
COPDGene, Genetic Epidemiology of COPD; FEV1, forced expira-
tory volume in 1 second; FVC, forced vital capacity; LVEF, left
ventricular ejection fraction; MRI, magnetic resonance imaging; RVEF,
right ventricular ejection fraction; RVESVI, right ventricular end sys-
tolic volume index; RVMI, right ventricular mass index; TLCpp, total
lung capacity, percent predicted.
Data were presented as n (%) and mean (±standard deviation).
TABLE 2. Correlation Coefficient (R) Between CT-derived
Cardiac Volume Measurements and Cardiac MRI-based
Volume and Mass Estimates in 24 Subjects
Cardiac MRI-derived Metrics
CT-derived Metrics RV ED VolumeMR RV ED MassMR
RV_EPI VolumeCT 0.65 (.0006) 0.60 (.002)
RV_ENDO VolumeCT 0.61 (.001) 0.57 (.004)
LV ED volumeMR LV ED massMR
LV_EPI volumeCT 0.61 (.001) 0.56 (.004)
LV_ENDO volumeCT 0.60 (.002) 0.51 (.01)
LV ED lengthMR
LV Long AxisCT 0.49 (.02)
LV mid ED curvatureMR
LV Free Wall
curvatureCT
0.70 (.0001)
LV ED radius ratioMR
LV sphericityCT 0.51 (.01)
RV/LV ED volume ratioMR
RV/LV volume ratioCT 0.46 (.02)
CT, computed tomographic; ED, end diastolic; LV, left ventricular;
MID, middle of ventricle; MRI, magnetic resonance imaging; RV, right
ventricular.
Spearman correlation coefficients, with accompanying P values.
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A subset of the echocardiogram reports also provided an
additional qualitative description of LV function (n = 180 where
the LV function was categorized as “normal” or “reduced”),
whereas some had quantitative estimates of the LVEF (n = 98
subjects). There were statistically significant differences in the
CT estimates of LV size and morphology between subjects
with reduced LV function (N = 18) and those with normal
LV function (N = 162) (Table 4). Subjects with a reduced EF
had larger LV size with lesser free-wall curvature on CT scan.
In the subjects with quantitative measurement of LVEF, a larger
LV size and reduced free-wall curvature were also predic-
tive of reduced LVEF.
Logistic regression models were constructed for the fol-
lowing variables: elevated RVSP (RVSP > 40 mmHg), reduced
RV function, and reduced LVEF (Table 5). RV volume was
a statistically significant predictor of both RVSP and RV failure,
with gender and age being independent predictors and effect
modifiers of this association. The final model for RVSP, which
included RV volume, age, gender, and the interaction terms,
had an area under the curve (AUC) of 0.77. The final model
for RV failure included age and gender and had an AUC of
0.76. LV volume (LV_EPI volumeCT) was predictive of de-
creased LVEF, and with the addition of body mass index, the
final model had an AUC of 0.71.
Figure 1. The right ventricle (blue) and left ventricle (red) in three subjects with a cardiac model fitted to the surface of the heart using
volumetric non-contrast computed tomographic scan. A subject with Gold 0 disease and with a right ventricular-to-left ventricular (RV-to-
LV) ratio of 0.5, RV systolic pressure (RVSP) of 20 and no evidence of ventricular dysfunction (a), subject with Gold 3 disease and RV/LV
ratio of 0.8, RV dilation, elevated RVSP of 47 (b), and subject with Gold 2 disease with LV dilation and ejection fraction of 35% (c).
TABLE 3. Correlation of CT-derived Right Ventricular Geometry With Echocardiogram-derived Geometric and Functional
Measures (First Three Columns) and the Difference in Those Metrics Between Patients Characterized as Having Abnormal
Versus Patients Having Normal RV Function
CT-derived Measures of
Right Ventricle
Echocardiogram-derived Measures
RV Minor
AxisECHO RVSP
Decreased
RV Function
Normal RV
Function
P(N = 238) (N = 194) (N = 10) (N = 120)
RV Long AxisCT R = 0.36, R = 0.28, 7.3[6.1–7.5] 6.9[6.4–7.3] .44
P < .0001 P < .0001
RV short AxisCT R = 0.44, R = 0.27, 4.3[4.0–4.7] 4.0[3.6–4.3] .03
P < .0001 P = .0002
RV_EPI volumeCT R = 0.46, R = 0.3, 106[87–117] 85[66–103] .04
P < .0001 P < .0001
RV_ENDO volumeCT R = 0.45 R = 0.28 67[54–79] 57[42–67] .06
P < .0001 P = .0001
RV surface areaCT R = 0.49, R = 0.24, 169[142–194] 148[130–169] .05
P < .0001 P = .0006
CT, computed tomographic; RA, right atrium; RV, right ventricle; RVSP, estimated right ventricular systolic pressure by echocardiogram.
Values shown are Spearman correlation coefficients (R) and P values associated with Spearman correlation. Values shown for subgroups
with decreased and normal RV function are shown as median [interquartile range].
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DISCUSSION
CT characterization of thoracic disease in smokers is increas-
ingly leveraged for clinical, epidemiologic, and genetic
investigation. Whereas previous investigations have demon-
strated the utility of CT-based assessments of the vascular tree
and atherosclerosis in smokers, little literature exists on di-
rectly modeling the heart from non-ECG-gated, non-
contrast CT data. Herein we report the development and
application of a model of cardiac structure based on a surface
fitting algorithm applied to non-cardiac-gated, non-contrast-
enhanced images. From this initial fit of the epicardial surface,
we made inferences about the right and the left epicardial (wall
and chamber) as well as endocardial (chamber) ventricular size
and shape. We found that CT-based measures of RV and LV
shape and size were significantly associated with MRI and
echocardiogram-based assessments of these same chambers. We
further found that such CT-based morphology had discrim-
inatory power in detecting abnormal ventricular function
detected by echocardiography.
MRI is considered a gold standard for the noninvasive as-
sessment of the cardiac structure. It can provide detailed
assessments of ventricular morphology and function without
decrements in image quality that are observed using
echocardiography in hyperinflated patients with COPD. Using
data from 24 subjects who underwent CT and MRI, we found
highly statistically significant associations between CT- and
MR-based measures of ventricular size and morphology. Up
to 50% of the variance in the MRI-based measures of ven-
tricular structure was explained by the CT data. These
associations were strongest with CT-based measures of LV
free-wall curvature and tended to weaken with measures of
volume. The latter is not surprising because the CT-based
model relies on statistical inference of septal location and mor-
phology. Because the cardiac MRI studies were obtained 3
years after the CT data, changes in the cardiovascular state
of the subjects in the interim could also introduce a differ-
ence between the two measurements.
There were also significant associations between our CT
measures of ventricular morphology and similar assessments
obtained from echocardiography. These correlations were of
the same direction and magnitude as those observed in the
MRI data. The larger sample size of echocardiogram data
allowed additional exploration of CT structure and cardiac
function. In these data, we again found highly plausible as-
sociations. Subjects with larger RVs on CT were more likely
to have elevated pulmonary arterial pressures (estimated by
RVSP) and decreased RV function. Subjects with an en-
larged left ventricle and reduced curvature of the free wall
on CT scan tended to have lower estimated LVEFs on
echocardiogram. These findings were further corroborated in
regression models adjusted for subject age and sex, where the
AUCs were greater than 0.75 (Fig 2). We suspect that the
reasons for this are not found in the detection of cardiac dis-
placement on CT but rather in the relationship between
TABLE 4. Correlation of CT-derived Left Ventricular Geometry With Echocardiogram-derived Functional Measures (First Three
Columns) and the Difference in Those Metrics Between Patients Characterized as Having Abnormal Versus Patients Having
Normal Left Ventricular Ejection Fraction
CT Measures of Left
Ventricle
ECHO-derived Measures
LVEF Reduced EF Normal EF
P Value(N = 98) (N = 18) (N = 162)
LV Long AxisCT R = −0.20, P = .05 8.54[7.69–9.21] 8.05[7.42–8.62] .08
LV_EPI volumeCT R = −0.22, P = .03 207.1[167.5–240.1] 173.1[143.8–199.2] .01
LV_ENDO volumeCT R = −0.23, P = .03 118.0[89.0–141.1] 97.1[78.4–111.6] .02
LV surface areaCT R = −0.21, P = .03 202.7[164.1–223.7] 176.6[153.1–197.0] .03
LV volume/surface AreaCT R = −0.18, P = .08 1.03[0.98–1.07] 0.97[0.92–1.02] .009
LV Free-Wall CurvatureCT R = 0.20, P = .04 0.018[0.0169–0.0195] 0.0192[0.18-0.0205] .03
EF, ejection fraction; LV, left ventricle.
Values shown are correlation coefficients (R) and P values associated with Spearman correlation. Values shown for subgroups with de-
creased and normal ejection fraction are shown as median [interquartile range].
TABLE 5. Logistic Regression Model Performance Based
on AUC (Area Under the Curve) for Models Predicting RVSP
>40, Reduced RV Function, Reduced LV Ejection Fraction,
and History of CHF
Model Variables
RVSP
>40 RVF
Reduced
LVEF
N = 194 N = 130 N = 180
(64/194) (10/130) (18/180)
AUC AUC
Model
Variables AUC
RVV 0.67 0.70 LVV 0.68
RVV+Age+Gender 0.75 0.75 LVV+BMI 0.71
RVV+Age+Gender
+RVV*Gender
0.77
LV, left ventricle; LVEF, left ventricular ejection fraction; LVV, left ven-
tricle volume; RV, right ventricle; RVF, evidence of RV failure on
echocardiogram; RVSP, estimated right ventricular systolic pres-
sures by echocardiogram; RVV, right ventricle volume.
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chamber structure and function. Deviations in structure likely
connote deviations in function where, for example, an en-
larged left ventricle is less likely to exhibit a normal EF.
There are several limitations to this work that must be ac-
knowledged. The first is the nature of the data obtained from
the CT-based surface fitting model. Because the cardiac struc-
tures below the epicardial surface are indiscernible on non-
contrast-enhanced, non-cardiac-gated CT scans, metrics of RV
and LV size were highly dependent on accurate estimates of
the location of the inter-ventricular septum. This is likely why
the strongest correlations between CT and MR tended to be
those assessing surface morphology rather than volume. CT
scans were obtained with an inspiratory hold, whereas mea-
surements in cardiac MRI are often obtained during expiratory
breath-holds. The type of breath-hold used in cardiac MRI
and echocardiography can significantly alter diaphragm po-
sition and preload, thus altering measurements of chamber
geometry. It must also be noted that the measures of curva-
ture from the MRI were obtained from the cardiac MRI report
and were not replicated using our techniques. It is highly likely
that there are differences in the location and technique used
to assess free-wall curvature between the CT and the MRI
data. Subtle differences in such techniques may result in large
differences in estimates given the eccentric surface of the ven-
tricles. The association of CT- and MRI-based measures of
ventricular morphology would likely be further improved if
the same operator performed the assessments using a single
technique. Another limitation to this investigation is the number
of subjects and timing of the MRI data collection, which was
obtained 3 years after the CT scan. Although this likely in-
troduced a source of error in the comparison between cardiac
MRI and CT scan, there is no a priori reason to suspect that
this would lead to overestimating the agreement between the
two modalities, whereas it is likely that it may have ac-
counted for part of the discrepancy between the two
measurements. The small sample size prevented detailed ex-
amination of CT morphology and MRI measures of cardiac
function. Progression of disease and changes in volume status
between the two imaging time points complicated this
comparison.
In conclusion, estimates of RV and LV size and morphol-
ogy can be obtained from volumetric CT data. These measures
are associated with structural and functional data obtained from
MRI and echocardiographic techniques. These techniques have
the capability of becoming fully automated and incorporat-
ed into the clinical reporting of CT data. Significant numbers
Figure 2. Model discrimination performance as measured by the area under the receiver operating characteristic curve, shown for four
logistic regression models constructed using a stepwise forward selection method for markers of cardiac dysfunction in the cohort with
available echocardiograms. A model of ability to predict right ventricular (RV) systolic pressure ≥40 (a), RV failure as marked on the echocardiogram
(b), and left ventricular failure defined by ejection fraction <55% (c).
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of CT scans are obtained in patients with lung disease, dyspnea,
and smokers, all of whom are at risk of cardiovascular disease,
and in the appropriate clinical settings, findings of abnormal
cardiac geometry on CT scan would then warrant further
cardiac examination. Cohorts specifically designed for assess-
ing the performance of these methods in screening for
cardiovascular disease are necessary to validate and optimize
this method and to minimize unnecessary follow-up testing
while improving clinical value. Additionally, methods of au-
tomated quantification of cardiac geometry can be broadly
deployed in CT-based clinical, epidemiologic, and genetic in-
vestigations of diseases affecting the chest.
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APPENDIX. SUPPLEMENTARY DATA
S upplementary data related to this article can be foundat http://dx.doi.org/10.1016/j.acra.2016.12.007.
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